Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2011-03-29
2011-03-29
Wessendorf, T. D. (Department: 1639)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S351000, C530S350000, C530S324000, C530S325000, C514S002600
Reexamination Certificate
active
07915221
ABSTRACT:
The present invention provides a method for the design and/or the selection of agonist or antagonist chemokine variants combining a phage display technology and a screening on living cells expressing the receptor of the corresponding native chemokine. It also provides RANTES variants having agonist properties towards said receptor, and methods for preventing and/or curing viral diseases, as well as clues for preventing and/or curing inflammatory or malignant diseases.
REFERENCES:
Hartley, Oliver et al.; Journal of Human Virology, vol. 3, No. 5, Sep. 2000, p. 242. XP 002233593.
Brown, K.C.,Current Opinion in Chemical Biology, Feb. 2000; vol. 4, No. 1, pp. 16-21, XP002233594.
Appay, Victor et al., Trends in Immunology, vol. 22, No. 2, Feb. 1, 2001; pp. 83-87; XP004323274.
Meta, Akihiro et al., Molecular Immunology, vol. 36, No. 18, Dec. 1999, pp. 1249-1254; XP002233595.
Houimel, Mehdi et al.; European Journal of Immunology, vol. 31, No. 12, Dec. 2001, pp. 3535-3545, XP002233596.
Zeng, Q.P. et al., May 31, 2000; NCBI Database Accession No. AAF73070, XP002233597.
Berger et al., Annual Review Immunol., vol. 17, pp. 657-700, (1999).
Cocchi et al., Science, vol. 270, pp. 1811-1815, (1995).
Skelton et al., Biochemistry, vol. 34, pp. 5329-5342, (1995).
Bazan et al., Nature, vol. 385, pp. 640-644, (1997).
Imai et al., J. Biol. Chem., vol. 272, pp. 15036-15042, (1997).
Moser et al., J. Biol. Chem., vol. 268, pp. 7125-7128, (1993).
Proudfoot et al., J. Biol. Chem., vol. 271, pp. 2599-2603, (1996).
Simmons et al., Science, vol. 276, pp. 276-279, (1997).
Mack et al., J. Exp. Med., vol. 187, pp. 1215-1224, (1998).
Signoret et al., J. Cell. Biol., vol. 151, pp. 1281-1294, (2000).
Yang et al., J. Virol., vol. 73, pp. 4582-4589, (1999).
Townson et al., J. Biol. Chem., vol. 275, No. 50, pp. 39254-39261, (2000).
Smith et al., Science, vol. 228, pp. 1315-1317, (1985).
Clarkson et al., Trends Biotechnol., vol. 12, pp. 173-184, (1994).
Hart et al., J. Biol. Chem., vol. 269, pp. 12468-12474, (1994).
Mosier et al., J. Virol., vol. 73, pp. 3544-3550, (1999).
Polo et al., Eur. J. Immunol., vol. 30, pp. 3190-3198, (2000).
Proost et al., J. Biol. Chem., vol. 273, pp. 7222-7227, (1998).
Pakianathan et al., Biochemistry, vol. 36, pp. 9642-9648, (1997).
Lowman et al., J. Mol. Biol., vol. 234, pp. 564-578, (1993).
Debre Patrice
Dorgham Karim
Gorochov Guy
Hartley Oliver
Offord Robin
Birch Stewart Kolasch & Birch, LLP.
Universite Pierre Et Marie Curie (Paris VI)
Wessendorf T. D.
LandOfFree
Methods for construction and screening of libraries of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for construction and screening of libraries of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for construction and screening of libraries of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2665675